G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $236,000 | -55.2% | 20,495 | -5.8% | 0.00% | -100.0% |
Q2 2020 | $527,000 | +34.8% | 21,754 | -38.7% | 0.00% | 0.0% |
Q1 2020 | $391,000 | -71.2% | 35,494 | -30.8% | 0.00% | 0.0% |
Q4 2019 | $1,356,000 | -19.5% | 51,303 | -24.6% | 0.00% | -50.0% |
Q3 2019 | $1,684,000 | +9.3% | 68,013 | +35.3% | 0.00% | +100.0% |
Q2 2019 | $1,541,000 | +162.1% | 50,272 | +42.0% | 0.00% | 0.0% |
Q1 2019 | $588,000 | +130.6% | 35,406 | +165.8% | 0.00% | – |
Q4 2018 | $255,000 | – | 13,323 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
RA Capital Management | 363,051 | $6,027,000 | 0.26% |
BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |